Open House Biologika Rabattverträge 2026-33 Pertuzumab / Trastuzumab (Wirkstoffkombination)
openRead the notice at vergabe-de ↗
Value
unstated
Published
4 Nov 2026
Deadline
—
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600DE501
Description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge § 130c Abs. 1 SGB V zu der Wirkstoffkombination Pertuzumab / Trastuzumab zu schließen.
Key facts
- Reference
- OH-Biologika-2026-33
- Procedure
- open
- Lots
- 1
- Contact
- DZEM@tk.de+49 4069094-040
- Regime
- publicSector
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- vergabe-de
- Notice id
- 27ee5488-9403-4139-bbdc-f9d831083e87
- OCID
- ocds-mnwr74-18e0f07e-57dc-4dab-968b-31cbbdcf6ba8
- First seen
- 7 Nov 2026
- Last updated
- 7 Nov 2026
Licence CC0 1.0 public domain dedication ↗
Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.
View at source ↗
GET /api/v1/tenders/35582703-f581-44f1-b653-5fd6645588a8The source notice is authoritative — verify deadlines and documents there before bidding.